pindolol has been researched along with Di Guglielmo Disease in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmitt, H | 1 |
| Pochet, R | 1 |
| Guyaux, M | 1 |
| Kram, R | 1 |
| Moudry, R | 1 |
| Porzig, H | 1 |
2 other studies available for pindolol and Di Guglielmo Disease
| Article | Year |
|---|---|
Characterization of beta-adrenergic receptors on Friend erythroleukemic cells [proceedings].
Topics: Benzyl Alcohols; Binding, Competitive; Cell Line; Friend murine leukemia virus; Kinetics; Leukemia, | 1978 |
Regulation of beta-adrenergic responsiveness during erythroid differentiation of Friend erythroleukemia cells.
Topics: Adrenergic beta-Antagonists; Animals; Cell Differentiation; Cell Membrane; Dimethyl Sulfoxide; Frien | 1990 |